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Abstract
Background: Chronic pelvic pain (CPP) is a complex condition wich is associated with emotional factors, specially depression and anxiety. Objectives: To 
make a systematic review to provide a detailed summary of relevant literature on the association between CPP and different psychiatric disorders/symptoms. 
Methods: A systematic review of articles in the international literature published between 2003 and 2014 was performed in the electronic databases PubMed, 
PsycINFO, LILACS, and SciELO using the terms (chronic pelvic pain) AND (psychiatry OR psychiatric OR depression OR anxiety OR posttraumatic stress OR 
somatoform). The searches returned a total of 529 matches that were filtered according to predefined inclusion and exclusion criteria. A total of 18 articles 
were selected. Results: The investigations focused mainly on the assessment of depression and anxiety disorders/symptoms, with rather high rates (17-38.6%). 
Depression and anxiety symptoms were more prevalent among women with CPP compared to healthy groups. Comparisons between groups with CPP and 
with specific pathologies that also have pain as a symptom showed that depression indicators are more frequent in CPP. Depressive symptoms tend to be more 
common in CPP and have no particular association with pain itself, the core feature of CPP. Discussion: Other aspects of CPP seem to play a specific role in 
this association. Anxiety and other psychiatric disorders require further investigation so that their impact on CPP can be better understood.
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Introduction
Chronic pelvic pain (CPP) is a common and disabling condition 
among women in reproductive age1,2 and is currently regarded as a 
public health problem3. International and Brazilian studies report 
prevalence rates of CPP ranging between 4% and 25.4%1,4-8. Although 
there is no complete agreement about the definition of CPP, the 
condition is characterized by the presence of continuous or inter-
mittent pain in the lower abdomen (below the navel) and/or in the 
pelvis, persistent for at least six months, not exclusively associated 
with menstruation, sexual intercourse or neoplastic disease, severe 
enough to cause disability or functional impairment, and requiring 
clinical and/or surgical treatment9-13.
CPP is a complex condition of usually unknown etiology and 
influenced by or resulting from the interaction of various systems, 
including the gastrointestinal, urinary and genital tracts, and neu-
rological and psychological aspects2. In up to 60% of cases, CPP is 
associated with emotional factors14, most commonly represented by 
depression and anxiety15. Researchers have been trying to identify 
the role played by emotional factors in the onset and maintenance 
of CPP, regarding such factors both as possible consequences of the 
chronic condition and also as etiological agents.
In this direction, evidence exists about the causal relationship 
between psychological factors and CPP, as women with the condition 
present significantly higher rates of psychiatric disorders as compared 
to control groups16-18. Other authors still report that negative mood 
and emotion can cause or increase pain19 and that the experience of 
pain, as a personal and subjective phenomenon, is probably affected 
by emotional states and, therefore, by psychosocial factors8.
Other investigators suggest exactly the opposite. To them, it is 
the context of chronic pain itself that favors feelings of frustration, 
preoccupation, anxiety, and depression8. Women with CPP have to 
deal with the loss of a healthy and active body and reach a state of 
dependence and disability that may be responsible for changes in 
affective, family, social, and sexual dynamics, thus having a negative 
impact on quality of life20. A study by Roth et al.21 investigated this 
hypothesis through the comparison of women with CPP and with 
other conditions involving chronic pain, especially migraine. Their 
findings showed that women with CPP were more dissatisfied with 
their marriage and capacity for sexual intercourse; however, no dif-
ferences were found in regard to indicators of depression and anxiety 
or personality traits. These data suggest that, in general, when CPP 
patients present with psychological disturbances, these are likely to 
reflect the effects of chronic pain.
It should be noted, however, that many studies had inconclusive 
results because of the methodology or design adopted, and that the 
role played by emotional factors in the onset and maintenance of the 
condition remains largely unknown8,20,22,23.
Despite the large number of studies investigating the association 
between CPP and different psychological and psychiatric aspects, 
no systematic reviews or meta-analyses have been published to date 
dealing with this topic and contributing to expand the comprehen-
sion of this association.
Objectives
The objective of this study was to perform a systematic literature 
review of articles published over the last 12 years in order to identify 
possible associations between CPP and different psychiatric disorders 
and/or symptoms.
Methods
This systematic review was conducted in accordance with the PRIS-
MA (Preferred Reporting Items for Systematic Reviews and Meta-
Analyses) Statement and the guidelines of the Cochrane Handbook 
for Systematic Reviews of Interventions.
We made a systematic search for articles published between 
January 2003 and July 2014 indexed in the online databases PubMed, 
PsycINFO, LILACS, and SciELO using the search expression (chronic 
pelvic pain) AND (psychiatry OR psychiatric OR depression OR anxiety 
OR posttraumatic stress OR somatoform). The searches returned a total 
of 529 matches that were filtered according to predefined inclusion 
and exclusion criteria, as shown in figure 1.
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Results
A total of 18 articles were selected and independently examined in 
respect to their adequacy for inclusion in the review by two psycholo-
gists and mental health researchers. From these, five studies24-28 used 
an observational descriptive design and the remaining 138,20,21,29-38 
used a case-control design. Most of the studies were conducted in the 
United States (n = 6) and Brazil (n = 5). Table 1 provides data on the 
studies’ design, country of origin, and main sample characteristics.
The clinical groups with CPP assessed in the studies included 
samples ranging between 12 and 713 subjects, with mean of 94.4 
and median of 44. Subjects had a mean age of 35.6 years and large 
variations in education. Most of the studies established the presence 
of CPP through clinical diagnosis (n = 14) and presence of pain for 
at least six months (n = 12).
Control groups consisted of samples ranging between 20 and 
1,131 subjects, with mean of 140.9 and median of 50. The mean age 
of participants in control groups was 35.3 years, equivalent to that 
of clinical groups, and similarly varied education. In general, control 
groups consisted of healthy women (n = 7) or people with other 
specific conditions involving pain (n = 8).
The most frequent inclusion criteria for the clinical groups were 
duration of pain symptoms8,20,21,24-27,29,31-36, which ranged from three to 
six months, and specificities related to the etiology of pain21,27,31-34,36,37, 
for example, pain resulting from pelvic adhesions. It is noteworthy 
that not all studies strictly followed the international criteria for the 
diagnosis of CPP, which require a minimum duration of six months 
for pain symptoms9-13.
Criteria for the inclusion in control groups consisted mainly of 
the absence of CPP20,21,27,29-36,38 and presence of other specific clinical 
conditions such as lower back pain and migraine27,29,30,34,36.
Figure 1. Flowchart showing the procedure of article selection and inclusion/
exclusion criteria.
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Exclusion criteria for the composition of CPP and control groups 
consisted mainly of the presence of other general (e.g.: interstitial 
cystitis, positive HIV, hypertension, diabetes) and/or gynecological 
conditions (e.g.: uterine fibroids and cysts) and pregnancy. It should 
be noted that nine studies24,26-28,29,31,33,34,36 described no exclusion 
criteria.
The main outcome measures assessed in the studies included 
(a) mood indicators (n = 17); (b) anxiety indicators (n = 9); and 
(c) somatization/dissociation indicators (n = 3). Table 2 shows the 
outcome measures and assessment instruments used in the studies 
reviewed.
As seen in table 2, a number of different instruments were used 
to assess outcome variables, most of which were self-rated. Mood 
indicators were mainly evaluated through the Beck Depression 
Inventory (BDI; n = 8; 44.4%), with only one study that reported 
the use of the Structured Clinical Interview for DSM-IV (SCID-
IV), regarded as the gold standard for psychiatric diagnoses. In the 
assessment of anxiety indicators, only the Beck Anxiety Inventory 
(BAI) and the Hospital Anxiety and Depression Scale (HADS) were 
used in more than one study. For the assessment of somatization 
and dissociation indicators, the SCID-IV was the main instrument 
of choice (n = 2).
The main associations between CPP and psychiatric disorders/
symptoms are shown in table 3.
The groups with CPP included in the studies had a high frequency 
of anxiety and depression symptoms, with respective prevalence 
rates of 38.6% and 29.5%. Relative to control groups, CPP subjects 
presented higher rates of depression (n = 7) and anxiety (n = 3), 
regardless of the instruments used in the assessments. Comparisons 
between groups with CPP and endometriosis concerning depression 
indicators showed that subjects with CPP had a higher frequency of 
mood symptoms.
When CPP groups were compared to control groups with chronic 
lower back pain, authors reported divergent findings related to de-
pression rates29,30, despite the fact that the two studies making these 
comparisons had similar sampling procedures and used the same 
assessment instrument. Another investigation found equivalent rates 
of depression and anxiety in subjects with CPP and migraine21, and 
two others found no differences when comparing CPP groups with 
different etiologies27,37.
There are reports of significant positive associations between 
CPP and anxiety, depression and dissociation indicators, pain, and 
physical or sexual abuse24,25,28,29,38. On the other hand, negative as-
sociations have been found between CPP and depression, anxiety, 
sexual adjustment and quality of life31,36.
Finally, bipolar affective disorder (BAD) was more prevalent 
in a group with endometriosis36 and post-traumatic stress disorder 
(PTSD) was found in 31.3% of a group of subjects with CPP26. 
Dissociative and somatoform symptoms were highly prevalent in 
samples with CPP24,33.
Discussion
This study systematically assessed the existence of associations be-
tween CPP and different psychiatric indicators/disorders through 
the exam of empirical articles published between 2003 and 2014.
Some remarks should be made concerning the methodological 
aspects of the studies included in this review, as they may affect the 
interpretation of the results presented. The first one refers to the study 
design adopted in the investigations, as 27.7% were descriptive studies. 
Also, there was great variability in the measures used, with a total of 18 
different instruments, which hinders direct comparisons between their 
results. Most of the studies reviewed used screening instruments (83.4%) 
based on self-report. Only three studies used the SCID-IV, a structured, 
clinician-rated diagnostic interview regarded as the gold standard for 
the establishment of psychiatric diagnoses. We conclude, therefore, that 
most studies assessed the presence of symptoms, and not disorders.
The fact that most studies focused on the assessment of symptoms 
of depression and anxiety is also noteworthy. Other disorders as, for 
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Table 1. Main characteristics of the samples in the studies reviewed
Ref. Authors Country
CPP groups Control groups
N
Mean 
age
(SD)
Education Marital status
CPP 
diagnosis
Duration 
of pain N
Mean age 
(SD) Education
Marital 
status
Clinical 
characteristics
29 Lampe  
et al. (2003)
Austria 43F 32.4(8.8) --- --- --- ≥ 6 
months
40F 40(9.1) --- --- Chronic LBP
22F 29.3(8.1) --- --- Healthy
24 Nijenhuis 
et al. (2003)
The 
Netherlands
52F 37.9(9.7) --- --- --- ≥ 6 
months
NA NA NA NA NA
30 Heinberg  
et al. (2004)
United 
States
22F 37.8(13.7) 14.7 
years
--- --- --- 22M 40.9(14.4) 14.5 years --- Men w/urogenital 
pain
22F 51(12.5) 13.8 years --- Women w/LBP 
28M 43.8(9.8) 13.5 years --- Men w/LBP
25 Poleshuck 
et al. (2005)
United 
States
63F 39.2(11.7) --- --- Clinical ≥ 6 
months
NA NA NA NA NA
31 Kaya et al. 
(2006)
Turkey 19F 34.1(9.3) --- --- Clinical ≥ 6 
months
25F 30.6(7.3) --- --- Healthy
32 Lorençatto 
et al. (2006)
Brazil 50F 35.3(6.4) --- 8 S
42 M
Clinical ≥ 6 
months
50F 32.8(7.1) --- 22 S
28 M
Endometriosis
26 Meltzer-
Brody et al. 
(2007)
United 
States
713F 35.3(9.8) 14.9 
years
--- Clinical ≥ 6 
months
NA NA NA NA NA
20 Romão  
et al. (2009)
Brazil 52F 31.7(8.1) 12BE; 
18ES; 
19HS; 
3SE
--- Clinical ≥ 6 
months
54F 30.3(6.2) 9BE; 19ES; 
25HS; 
1SE
--- Healthy
33 Wingenfeld 
et al. (2009)
Germany 18F --- --- --- Clinical ≥ 4 
months
24F --- --- --- Healthy
34 Kumar  
et al. (2010)
India 100F --- --- --- Clinical ≥ 6 
months
100F --- --- --- Endometriosis
100F --- --- --- Healthy
35 Barcelos  
et al. (2010)
Brazil 30F 35.2(7.5) 7.5 years 22 M Clinical ≥ 6 
months
20F 36(9.3) 8.5 years 13 M Other gynecological 
conditions
36 Kumar  
et al. (2011)
Canada 12F 35.6(---) --- --- Clinical + 
laparoscopy
≥ 6 
months
27F 30.3(---) --- --- Endometriosis
8 Silva et al. 
(2011)
Brazil 147F 40.4(15) 54 ES 15 S
8 D
31 M
Clinical ≥ 6 
months
1,131F 43(15.6) 305 ES 402 S
225 D
504 M
Healthy
27 Souza et al. 
(2011)
Brazil 57F 35.8(8.6) --- --- Clinical > 6 
months
NA NA NA NA NA
21 Roth et al. 
(2011a)
United 
States
39F 33.5(10.5) 4.9 years --- Clinical > 3 
months
38F 36.3
(11.1)
5.4 years --- Migraine
37 Roth et al. 
(2011b)
United
States
30F --- --- --- Clinical + 
laparoscopy
--- 70F --- --- --- Myofascial pain
38F --- --- --- Pelvic adhesions
38 Demir et al. 
(2012)
Turkey 44F 35.6(9.9) 35 ES; 9 
HS
--- --- --- 31F 38.8(4.2) 26 ES
5 HS
--- Healthy
28 As-Sanie  
et al. (2014)
United 
States
273F 34.8(11.3) 11 BE; 
126 HS; 
136 SE
97 S; 
139 
M; 23 
D; 14 
other
Clinical --- NA NA NA NA NA
M: married; D: divorced; S: single; CPP: chronic pelvic pain; BE: basic education; ES: elementary school; HS: high school; SE: superior education; F: female; M: male; LBP: lower back pain; NA: not applicable.
example, dysthymia and personality disorders, among others, were 
not contemplated, and attention to these conditions could be relevant 
for a better comprehension of psychic conditions associated with CPP.
Specifically in respect to the results of the studies reviewed, 
investigations using a case-control design enrolled healthy subjects 
and/or subjects with other pathological conditions associated or not 
with the presence of pain in their control groups. When assessing the 
prevalence rates reported in descriptive studies, depression and anxi-
ety rates (29.5% ad 38.6%, respectively) are much higher than those 
found in the general population by a recent Brazilian epidemiological 
survey (9.4% and 19.9%, respectively)39. These rates are also higher 
than those reported by international epidemiological studies, as the 
one by Kessler et al.40 in which the lifetime rates of depression and 
anxiety were respectively 18.3% and 21.4% in an adult population. 
This large difference should be regarded with caution since the studies 
reviewed here assessed symptoms and not the presence of disorders 
as in epidemiological surveys. Still, however, the rates are high and 
should be considered as signs of increased difficulties.
Studies involving control groups formed by healthy subjects 
found that depression was more prevalent among women with CPP 
(n = 7), regardless of the instruments used to measure depression 
indicators. The same result was found by studies comparing anxiety 
in women with CPP and healthy women (n = 3), with the exception 
of the study by Kaya et al.32, where no differences were found.
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Table 2. Outcome variables and instruments used in the studies (N = 19; non-exclusive categories)
Outcome variables Instruments
Psychiatric symptoms 
and disorders
(N = 18)
Mood disorders/symptoms
(N = 17)
Depression/depressive symptoms: 
N = 168,20,21,24,25,27-35,37,38 
BDI (N = 8)21,27,29-32,37,38
BSI (N = 1)25,37
HADS (N = 2)20,24
CESD (N = 1)28,30
SRDS (N = 1)33
DDS (N = 1)34
SCID-IV (N = 1)36
Self-report (N = 1)35
Semi/structured interview (N = 1)8
BAD: N = 1 
Anxiety disorders/symptoms
(N = 9)
Anxiety symptoms: 
N = 88,20,21,24,25,27,31,38
BAI (N = 2)31,38
HADS (N = 2)20,24
BSI (N = 1)25
SPAN (N = 1)26
STAI (N = 2)21,31
HARS (N = 1)27
Semi/structured interview (N = 1)8
PTSD: N = 126
Somatization/
dissociation
(N = 3)
N = 324,33,38 STSD (N = 1)24
SCID IV (N = 2)24,33
SDQ (N = 1)24
DES (N = 1)24
IPPS (N = 1)38
BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; BSI: Brief Symptom Inventory; CESD: Center for Epidemiological Studies – Depression scale; DDS: Deep Depression Scale; DES: Dissociative 
Experiences Scale; HADS: Hospital Anxiety and Depression Scale; HARS: Hamilton Anxiety Rating Scale; IPPS: International Pelvic Pain Society questionnaire, SCID-IV: Structured Clinical Interview 
for DSM-IV; SDQ: Somatoform Dissociation Questionnaire; SPAN: Startle, Physiological Arousal, Anger and Numbness scale; SRDS: Self-Rating Depression Scale; STAI: State-Trait Anxiety Inventory; 
STSD: Screening Test for Somatization Disorder; BAD: Bipolar Affective Disorder; PTSD: Post-traumatic Stress Disorder.
Table 3. Main associations between CPP and psychiatric disorders and symptoms reported in the studies, with outcome variables as parameters
Psychiatric 
disorders 
and 
symptoms 
(N = 18)
Mood 
disorders/
symptoms 
(N = 17)
Depression/
depressive 
symptoms:  
N = 16 
CPP = 29.5% depression (N = 1)38
CPP  > healthy (N = 7)8,20,29,31,33-35
        > CLBP/UGP (N = 1)30
        > endometriosis (N = 3)32,34,36
CPP < CLBP (N = 1)29
CPP = migraine (N = 1)21
        = different etiologies (N = 2)27,37
↑ depression: ↑ dissociation (N = 1)24
                        ↑ HPA axis activity (N = 1)33
                        ↑ pain (N = 1)38
                        ↑ sexual/physical abuse (N = 2)25,28,29
                        ↓ sexual adjustment (N = 1)31
                        ↓ QOL (N = 1)36
BAD: N = 1 CPP < endometriosis (N = 1)36
Anxiety 
disorders/ 
symptoms 
(N = 9)
Anxiety 
symptoms: 
N = 8 
CPP = 38.6% anxiety (N = 1)38
CPP > healthy (N = 3)8,20,35 
CPP = healthy (N = 1)31
        = migraine (N = 1)21
        =  different etiologies (N = 1)27
↑ anxiety: ↑ dissociation (N = 1)24
                  ↑ sexual/physical abuse (N = 1)25
                  ↑ pain (N = 1)38
                  ↓ sexual adjustment (N = 1)31
                  ↓ QOL (N = 1)36
PTSD: N = 1 CPP = 31.3% PTSD (N = 1)26
Somatization/
dissociation 
(N = 3)
CPP = 26.9% dissociative symptoms (N = 1)24
CPP = 100% somatoform pain (N = 1)33
       = 6.8% somatization disorder (N = 1)38
↑ dissociation: ↑ somatization (N = 1)24
                         ↑ traumatic experiences (N = 1)24
< : lower; > : higher; ↑ : increased; ↓ : decreased; CLBP: chronic lower back pain; CPP: chronic pelvic pain; UGP: urogenital pain; HPA: hypothalamic-pituitary-adrenal; QOL: quality of life; BAD: bipolar 
affective disorder; PTSD: post-traumatic stress disorder.
Few studies included in the review (n = 5) compared groups with 
CPP and groups of subjects with specific pathologies that included 
pain as a symptom (namely, lower back and/or urogenital pain, mi-
graine, and endometriosis) in an attempt to ascertain the influence 
of this variable. These investigations used common instruments 
and suggest that depression indicators tend to be more frequent in 
CPP groups, which opens the perspective to think of the existence 
of particular characteristics of CPP that associate with depression 
besides pain alone. In relation to anxiety, this type of comparative 
study is still scarce and do not allow for conclusions.
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It should be noted that indicators of depression and anxiety va-
ried between groups of CPP with different etiologies (endometriosis, 
myofascial pain, pelvic adhesions etc.), with inconclusive results from 
the different studies in the area.
Bipolar affective disorder was found in 44.4% of women with 
CPP associated with endometriosis, while no women with CPP 
without endometriosis presented this psychiatric condition. The 
fact that the rate of BAD in the general Brazilian population was 
estimated in 1.5%39 makes it difficult to explain the high frequency 
of this condition in the CPP group with associated endometriosis. 
However, if we consider CPP alone, the rate of BAD is close to that 
of the general population, or even smaller.
In CPP groups, the results available show associations of the 
condition with rates of depression and anxiety and increased pres-
ence of dissociation, pain, and physical and/or sexual abuse. On 
the other hand, reduced sexual adjustment and quality of life were 
negatively associated with these rates. These data raise the hypothesis 
of a possible chain reaction in which trauma, such as sexual abuse 
in childhood, could contribute to the etiology of CPP and also to 
the increase in depressive and dissociative experiences and somatic 
conditions25,28,29, in addition to having a negative impact on quality of 
life and sexual adjustment. The experience of these impairments and 
difficulties may feed back the chain, favoring experiences of anxiety 
and depression, which may also act as risk factors for the increase 
in experiences of pain, especially of somatic origin.
Along the same line, PTSD was observed in 31.3% of women 
with CPP, once again a high rate as compared with national39 and 
international40 data pointing to prevalence rates of 1.6% and 8%, 
respectively, in the general population. By relating these findings to 
the significant rates of dissociative symptoms and somatoform pain 
in CPP groups, we can again hypothesize that trauma might be a 
risk factor for the development of CPP. Only one study28, however, 
included logistic regression in its analysis. Future studies with this 
focus are therefore extremely necessary to provide evidence concern-
ing the predictive role of trauma in the development of CPP.
In conclusion, depressive symptoms tend to be more present 
in CPP and this relationship does not seem to be specifically con-
nected to pain, a core feature of CPP. Other factors particular to CPP 
seem to be implicated in this association. In this review, we found 
that traumatic experiences in childhood or adult life are some of 
the aspects that deserve attention. Also, anxiety and other specific 
disorders assessed, such as BAD, PTSD, and somatization disorder, 
require further investigation for the establishment of their role in CPP.
Directions for future research include: (a) greater methodological 
refinement involving other study designs, such as logistic regression, 
to investigate the impact of specific variables like early trauma; (b) 
detailed assessment of variables related to the duration and intensity 
of pain; and (c) use of diagnostic instruments with greater specificity 
and reliability.
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